Editas Medicine, Inc.EDITNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank58
5Y CAGR-40.5%
Year-over-Year Change
Year-over-year revenue growth rate
5Y CAGR
-40.5%/yr
Long-term compound
Percentile
P58
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 25.39% |
| 2024 | -58.64% |
| 2023 | 296.32% |
| 2022 | -22.83% |
| 2021 | -71.85% |
| 2020 | 341.93% |
| 2019 | -35.71% |
| 2018 | 132.64% |
| 2017 | 126.80% |
| 2016 | 271.58% |